• Home
  • Leadership
  • Policy Areas
  • Resources
News
02.28.23

RDCC Participates in FDA Rare Disease Day 2023 Public Meeting

Read more
News
01.20.23

Hopes, Fears for Orphan Drug Act

Read more
News
12.08.22

Vital Health Podcast: The Accelerated Approval Pathway is Vital for Rare Disease Treatments

Read more
News
11.28.22

RARECast Podcast: Examining the Legislative Landscape for Rare Disease Drug Development

Read more
News
11.22.22

Groups Hope New Congress Will Pass Bipartisan Bills Centered on Rare Diseases

Read more
News
11.15.22

New Study Finds Patient Access to Rare Disease Drugs Would Decline Sharply Under Proposals to Limit Medicaid Reimbursements

Read more
News
10.12.22

RDCC Joins in Call for Repeal of R&D Tax Policy that Hurts Rare Disease Innovation

Read more
News
09.12.22

RDCC Joins in Support of “Newborn Screening Saves Lives Reauthorization Act of 2021” in Letter to Senate Leaders

Read more
News
02.07.22

RDCC Advocates for “Newborn Screening Saves Lives Reauthorization Act of 2021” in Letter to Congressional Leaders

Read more
News
12.29.21

Cutting the Orphan Drug Tax Credit is Not Drug Pricing Reform

Read more
News
08.03.21

Rare Disease Drugmakers to Congress: Don’t Gut the Accelerated Approval Pathway

Read more
News
08.03.21

Drug Makers To Congress: Reject Accelerated Approval Pay Reforms

Read more
News
05.13.21

Rare Disease Companies Unite to Advocate for Life-Changing Therapies

Read more

©2023 The Coalition for Research, Access, Reform, and Equality for Rare Diseases (RARE). All rights reserved.

Privacy Policy